|
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer |
|
|
|
Titel: |
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer |
Auteur: |
Crown, J. Kennedy, M.J. Tresca, P. Marty, M. Espie, M. Burris, H.A. DeSilvio, M. Lau, M.R. Kothari, D. Koch, K.M. DiƩras, V. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 24 () nr. 8 pagina's 2005-2011 |
Jaar: |
2013 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|